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Abstract
The intracellular pathogen Brucella abortus survives and replicates inside host cells within an endoplasmic reticulum (ER)-
derived replicative organelle named the ‘‘Brucella-containing vacuole’’ (BCV). Here, we developed a subcellular fractionation
method to isolate BCVs and characterize for the first time the protein composition of its replicative niche. After identification
of BCV membrane proteins by 2 dimensional (2D) gel electrophoresis and mass spectrometry, we focused on two eukaryotic
proteins: the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the small GTPase Rab 2 recruited to the vacuolar
membrane of Brucella. These proteins were previously described to localize on vesicular and tubular clusters (VTC) and to
regulate the VTC membrane traffic between the endoplasmic reticulum (ER) and the Golgi. Inhibition of either GAPDH or
Rab 2 expression by small interfering RNA strongly inhibited B. abortus replication. Consistent with this result, inhibition of
other partners of GAPDH and Rab 2, such as COPI and PKC i, reduced B. abortus replication. Furthermore, blockage of Rab 2
GTPase in a GDP-locked form also inhibited B. abortus replication. Bacteria did not fuse with the ER and instead remained in
lysosomal-associated membrane vacuoles. These results reveal an essential role for GAPDH and the small GTPase Rab 2 in B.
abortus virulence within host cells.
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Introduction
Brucella abortus invades both phagocytic and non-phagocytic cells
[1–6] residing inside a membrane-bound compartment called the
Brucella-containing vacuole (BCV). Bacteria ensure their survival
and replication within host cells by avoiding fusion with lysosomes
and by controlling interactions with the endoplasmic reticulum
(ER) [1,5]. The membrane of the BCV is converted into an ER-
derived organelle that is permissive for replication [1]. Interactions
between BCV and ER occur at dynamic membrane complexes
named ERES for ER exit sites, where membrane fusion and fission
events take place. These events are regulated by the small GTPase
Sar 1. Sar 1 controls the assembly of COPII complexes on the ER
mediating vesiculation and tubulation of the ER membrane
towards the Golgi apparatus [7–9]. These events were shown to be
essential for B. abortus intracellular replication at early stages of
infection [10]. The Brucella replicative organelle has been, until
now, characterized by the presence of ER chaperones such as
calnexin, calreticulin, the translocator sec61b, and the ER resident
enzyme protein disulfide-isomerase PDI [1,5,11]. Aside from these
ER resident proteins, no other eukaryotic or prokaryotic proteins
have been associated with the BCV membrane as yet, identifica-
tion of these proteins is essential to understand how Brucella
maintains interactions with the ER and keeps replicating within
this compartment. In this work, we investigated by proteomic
approaches, the composition of the BCV membrane and
characterized 2 eukaryotic proteins that are essential for B. abortus
survival. We modified a fractionation method, initially used to
analyse latex bead-containing phagosomes [12,13], to isolate
BCVs obtained from cells infected with B. abortus. Mass
spectrometry analysis of BCV proteins separated by two-
dimensional (2D) gel electrophoresis revealed the presence of the
eukaryotic protein GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase). Further work on GAPDH revealed a role for GAPDH
and the small GTPase Rab 2 in the intracellular replication of B.
abortus.
Results
Survival and Replication of B. abortus inside BHK-21 Cells
To analyse the protein composition of the BCV membrane, a
large number of purified BCVs is required. We first tried to
determine which cell type was more susceptible for B. abortus
infection by monitoring the infection of primary phagocytic cells
(bone marrow-derived macrophages: BMDM) and phagocytic and
non phagocytic cell lines (Raw 264.7, HeLa, baby hamster kidney:
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of infected cells at 48 h post-infection (p.i.) between the different
cell types (nearly 35% infected cells), the intracellular replication of
B. abortus was 10 times higher within BHK-21 cells than in the
other cell types (Figure 1A).
As in macrophages [1] and in dendritic cells [14], B. abortus GFP
(in green) in BHK-21 cells were located inside a membrane-bound
vacuole labelled with the ER marker calnexin (in red), suggesting
that B. abortus replicates in ER-derived compartments within
BHK-21 (Figure 1B). This result was confirmed by electron
microscopy analysis of infected cells (Figures 1C, 1D and 1E). B.
abortus was located inside a membrane-bound compartment
resembling the ER with ribosomes lining the vacuolar membrane.
However, unlike what has previously been described in BMDM
and HeLa cells [1,5], several bacteria resided inside a unique
vacuole (Figures 1C and 1D). This may explain the increase of B.
abortus intracellular replication within BHK-21 cells. Taken
together, these results show that B. abortus extensively replicates
in an ER-derived compartment in BHK-21 cells, validating BHK-
21 cells as a good cell model for studying the proteic composition
of BCV membranes.
Isolation of BCVs
In order to obtain high concentration of membrane proteins, we
optimized a fractionation method to isolate and purify BCVs.
Within the post-nuclear supernatant (PNS) of BHK-21 cells
infected with B. abortus for 48 h, approximately 1.5% of vesicles
were GFP positive as detected by flow cytometry and we found
that 67% of BCVs remained positive for the ER marker calnexin
(Figure S1). After PNS preparation, BCVs were first purified on a
50%–12% sucrose gradient. BCVs were present at the interface,
which corresponded to 37% sucrose as indicated by the
densitometer measurement (data not shown). Bacteria were only
detected in the interface fraction (Figure 2A, lane F) by the
presence of the Brucella transmembrane outer membrane protein
Omp 25 [15]. On the contrary, ER was detected in each fraction
of the sucrose gradient with an anti-calnexin antibody (Figure 2A).
This first purification step allowed the elimination of Rab 7-
positive late endosomes and cathepsin D-positive lysosomes from
the BCV membrane fraction (Figure 2A, lane F). The interface
fraction was then loaded onto a second sucrose step gradient. This
gradient allowed the removal of early endosomes (Figure 2A, lane
H) and ER structures non-associated with the BCV as detected by
immunofluorescence and electron microscopy (data not shown).
Although the fraction of BCVs was now devoid of endocytic
organelles (Figure 2A, lane H), a few mitochondria detected by the
anti-mitochondrial VDAC 1 protein antibody were still present.
These could be eliminated by incubating the interface fraction
with dynabeads (M-500 subcellular) coated with anti-VDAC 1
antibody, but most of BCVs were lost (data not shown). As a
consequence, for proteomic analysis we chose not add the
dynabeads step. We analysed BCVs by immunofluorescence and
electron microscopy to determine if BCVs were still intact after
fractionation. 77% of B. abortus GFP were surrounded by ER-
positive vacuoles (Figure 2B). Electron microscopy analysis showed
that BCVs were still intact after subcellular fractionation
(Figure 2B). Bacteria were surrounded by an ER membrane-
bound compartment and residual ribosomes were still located on
the ER vacuolar membrane. Taken together, these data indicate
that we successfully isolated BCVs and preserved their membrane
integrity.
Determination of BCV protein composition
To determine the protein composition of the BCV membrane,
vacuolar proteins were solubilized by a mild Triton X-100
treatment, precipitated by a trichloroacetic acid/acetone and
analysed by 2D gel electrophoresis. Approximately one hundred
spots were detected by silver gel staining (Figure 2C) and further
analysed by mass spectrometry. Proteins of the BCV membrane
identified by mass spectrometry are listed in Table S1. Spot
numbers on 2D gel (Figure 2C) correspond to the numbers of
identified proteins listed in Table S1. As expected, 18% of proteins
identified were ER proteins (i.e. calreticulin, ERP 57 and PDI) and
13% ribosomal proteins confirming that the replicative niche of B.
abortus is derived from the ER. Interestingly, 29% of proteins were
not ER-related proteins (19% bacterial and 10% eukaryotic
proteins). The remaining 40% proteins were mitochondrial
proteins. Among the identified proteins, we focused on one
peculiar eukaryotic protein: the Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) annotated by spot number 49 on the
2D gel (Figure 2C) and in Table S1. GAPDH has multiple
functions within host cells such as glycolysis and apoptosis [16,17]
More interestingly, GAPDH interacts with the small GTPase Rab
2 to control vesicular retrograde transport between the ER and the
Golgi [18]. The presence of GAPDH on the BCV membrane
leads us to hypothesise that vesicular retrograde transport may be
involved in Brucella replication within the ER. Therefore, we
investigated the role of GAPDH and Rab 2 in Brucella survival
within host cells.
GAPDH and Rab 2 are present on BCV membranes
First, the presence of GAPDH on the BCV membrane was
confirmed by immunoblotting (Figure 3A, lane C). Its partner, the
small GTPase Rab 2, was also detected in the enriched BCV
fraction (Figure 3A, lane C). The small GTPase Rab 1, which is
known to be a resident of the ER as well as vesicular and tubular
clusters (VTCs) and Golgi apparatus [19,20] was also detected in
BCVs (Figure 3A, lane C). As no commercial antibody was
suitable for immunofluorescence detection of GAPDH on BCVs
Author Summary
A key determinant for intracellular pathogenic bacteria to
ensure their virulence within host cells is their ability to
bypass the endocytic pathway and to reach a safe
replication niche. Brucella bacteria reach the endoplasmic
reticulum (ER) to create their replicating niche called the
Brucella-containing vacuole (BCV). The ER is a suitable
strategic place for pathogenic Brucella. Bacteria can be
hidden from host cell defences to persist within the host,
and can take advantage of the membrane reservoir
delivered by the ER to replicate. Interactions between
BCV and the ER lead to the presence of ER proteins on the
BCV membrane. Currently, no other proteins (eukaryotic or
prokaryotic) have yet been associated with the BCV
membrane. Here we show that non-ER related proteins
are also present on the BCV membrane, in particular, the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
the small GTPase Rab 2 known to be located on secretory
vesicles that traffic between the ER and the Golgi
apparatus. GAPDH and the small GTPase Rab 2 are
involved in Brucella replication at late post-infection.
Similarly, integrity of secretory vesicle trafficking is also
necessary for Brucella replication. Here, we show that
recruitment of the two eukaryotic proteins GAPDH and
Rab 2 on BCV membranes is necessary for the establish-
ment of the replicative niche by sustaining interactions
between the ER and secretory membrane vesicles.
Brucella Interacts with VTCs
PLoS Pathogens | www.plospathogens.org 2 June 2009 | Volume 5 | Issue 6 | e1000487Figure 1. Survival and replication of B. abortus inside BHK-21 cells. (A) Fold increase of intracellular replication of B. abortus over 48 h within
3 different cell types: BHK-21 fibroblasts, BMDM and Raw 264.7 macrophages. Data are means6SD of three independent experiments. (B) Confocal
microscopy micrographs of BHK-21 infected for 48 h with B. abortus expressing GFP. Fixed cells were stained with anti-calnexin antibody (red) to label
the ER. (Scale bars: 10 mm). (C) Electron microscopy micrographs of thin sections of BHK-21 cells infected with B. abortus and fixed 48 h later. General
view of an infected cell displaying several BCVs. Note that most BCVs contain more than one bacterium. (D) Enlarged view of a BCV containing several
bacteria. (E) Enlarged view of part of the BCV shown in D. Note the ribosomes along the BCV membrane (arrows). (Scale bars: 0.5 mm).
doi:10.1371/journal.ppat.1000487.g001
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PLoS Pathogens | www.plospathogens.org 3 June 2009 | Volume 5 | Issue 6 | e1000487Figure 2. Biochemical and microscopic analysis of purified BCV. (A) Western blotting of each step of the fractionation method: A/Intact BHK-
21, B/BHK-21 homogenate, C/PNS, D/Supernatant after sucrose gradient, E/Sucrose 12%, F/Interface 50%–12%, G/Sucrose 50%, H/Sucrose step
gradient. Immunoblotting with anti-calnexin, -cathepsin D, -VDAC 1, -Rab 5, -Omp 25 and -Rab 7 antibodies. (B) Confocal microscopy micrographs of
isolated BCVs from the PNS and the sucrose step gradient. B. abortus express GFP (green) and the ER is labelled with anti-calnexin antibody (red).
(Scale bars: 5 mm). Electron microscopy micrographs of thin sections of isolated BCVs within the sucrose step gradient. The ribosomes along the BCV
membrane are indicated by arrows. They seem to be as abundant along the BCV membrane as in intact cells (Scale bars: 0.5 mm). (C) 2D gel
electrophoresis of BCVs membrane stained with PlusOne Silver Staining Kit. Each spot analysed by Mass Spectrometry is encircled and annotated
with the corresponding number.
doi:10.1371/journal.ppat.1000487.g002
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partner the small GTPase Rab 2. We found that 35% of isolated
BCVs were surrounded by Rab 2 staining (Figure 3B). Together
these results confirm the presence of GAPDH and Rab 2 on
BCVs. We further studied the role of Rab 2 and GAPDH in HeLa
cells, a well-established cell culture model for Brucella infection.
Rab 2 is involved in intracellular replication of B. abortus
We showed that the GTPase Rab 2 is present on the vacuolar
membrane of purified BCVs at 48 h p.i. (Figure 3A and 3B). In
order to determine the kinetics of Rab 2 acquisition on BCV
membranes, we first examined the presence of endogenous Rab 2
on BCVs within infected HeLa cells. Although we could detect
Rab 2 on isolated BCVs, labelling of infected cells was extremely
weak. As a consequence, we overexpressed Rab 2 within HeLa
cells by using a dominant positive form of Rab 2: Rab 2 Q65L,
which corresponds to Rab 2 locked in its GTP-bound form. HeLa
cells were transfected with Myc Rab 2 dominant positive Q65L for
24 h and then infected with B. abortus GFP. The intracellular
replication of Brucella within cells transfected or not with Q65L
Rab 2 was similar (data not shown). Figure 4A represents the
quantification of BCVs positive for Rab 2 Q65L at different times
p.i. At 6 h p.i. few BCVs were surrounded by the active form of
Rab 2 (2064.2%). Then, at 10 h p.i. 68.465.7% of BCV had
acquired Rab 2 Q65L and remained positive for Rab 2 Q65L
until 48 h p.i. Figure 4B illustrates the recruitment of Rab 2 on
BCVs at 10 h p.i. as indicated by the arrow. These results indicate
that the recruitment of the active form of Rab 2 takes place just
before the interaction of BCVs with the ER, known to occur
around 12 h p.i [5]. Indeed, most of BCVs surrounded by Rab 2
Q65L were still LAMP-1-positive at 10 h p.i. (data not shown).
Retrograde vesicle formation from the VTC is mediated by the
exchange of GDP to GTP on the GTPase Rab 2 [21]. In order to
inhibit the retrograde transport between the ER and the Golgi, we
used a dominant negative form of Rab 2: Rab 2 I119, which
corresponds to Rab 2 locked in its GDP-bound form. HeLa cells
infected with B. abortus Ds Red were transfected with either GFP
plasmid as a transfection control, myc Rab 2, myc Rab 2
dominant negative I119, GFP Rab 1 or GFP Rab 1 dominant
negative S25N. Figures 5A, 5B and S2A illustrate the level of
intracellular replication at 48 h p.i. in the different transfected
cells. We observed extensive Brucella replication in control cells or
cells transfected either with GFP or myc Rab 2 (Figure 5A, 5B and
S2A). Interestingly, transfections with either the GFP Rab 1 or its
dominant negative did not affect Brucella replication, contrasting
with results obtained from cells infected with Legionella pneumophila
and transfected with the dominant negative Rab 1 S25N (Figure
S2) [22]. On the contrary, in cells transfected with myc Rab 2
dominant negative I119 (Figure 5A and 5B), Brucella replication
was strongly decreased (six times) and 89.861.62% of the bacteria
were located in a lysosomal LAMP-1-positive compartment at
48 h p.i (Figure 5C and S2B), a time point were most of the
Brucella (88%) are within an ER-positive, LAMP-1-negative
compartments (Figure 5C and 5D). This shows that in cells
transfected with the Rab 2 dominant negative form, Brucella was
not able to reach the ER. Indeed, only a small percentage of BCVs
were positive for cathepsin D at 48 h p.i. (22% of BCVs within
cells overexpressing Rab 2 dominant negative) (Figure 5E). In
contrast 92% of heat-killed Brucella BCVs were already cathepsin
D-positive at 2 h p.i. (data not shown). Therefore, inhibition of
retrograde vesicle formation from the VTCs mediated by Rab 2
affects Brucella replication. Taken together these results indicate
that the trafficking between ER and Golgi controlled by Rab 2 is
important for entry of Brucella in the ER and subsequent
intracellular replication.
The early secretory pathway between ER and Golgi is
involved in Brucella replication
To investigate the role of GAPDH on Brucella pathogenesis, we
down-regulated the expression of GAPDH in HeLa cells infected
with B. abortus by using small interfering RNA. HeLa cells
transfected with GAPDH siRNA for 72 h efficiently and
specifically reduced the expression level of GAPDH (Figures 5F
and 5H), whereas, siRNA control did not affect the GAPDH
expression (Figures 5F and 5H). Inhibition of GAPDH expression
induced a 10 fold reduction in Brucella replication as compared to
non-transfected cells or cells transfected with the siRNA control
(Figure 5G and 5H). This result indicates that the presence of
GAPDH on the BCV membrane is required for Brucella
replication. We showed above that in cells transfected with the
Rab 2 dominant negative form, Brucella was not able to reach the
ER and remained in a LAMP-1 compartment. Similarly, in
siRNA GAPDH-treated cells, Brucella was found in a LAMP-1-
positive compartment (Figure S3). In addition, inhibition of
GAPDH expression prevented Rab2 recruitment on BCVs, as
shown after BCV purification (Figure S3). Quantification showed
that 77% of BCVs were positive for Rab 2 in control cells whereas
only 12% of siRNA GAPDH-treated cells were able to recruit Rab
Figure 3. GAPDH and Rab 2 localise to the BCV membrane. (A) Western blotting of the enriched fraction of BCVs: A/Interface 50%–12%, B/
Sucrose 50%, C/Sucrose step gradient. Immunoblotting with anti-GAPDH, anti-Rab 1 and anti-Rab 2 antibodies. (B) Confocal microscopy micrographs
of isolated BCVs from the sucrose step gradient. B. abortus GFP (green) and Rab 2 staining (red). (Scale bars: 5 mm).
doi:10.1371/journal.ppat.1000487.g003
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BCV biogenesis.
GAPDH is known to play several functions within host cells
[16–18,23]. To confirm the involvement of the retrograde
transport of the early secretory pathway in Brucella pathogenicity,
we investigated the role of other key components known to control
the vesicular trafficking between ER and Golgi, such as the kinase
PKC i/l and the coat COPI complex. Inhibition of these
components was performed by infecting HeLa cells transfected
with small interfering RNAs. We used a PKC i siRNA to silence
the expression of the kinase PKC i/l, a COP B siRNA to silence
the subunit b of the COPI complex, a Rab 2 A siRNA to silence
the GTPase Rab 2 and a a-Enolase siRNA to silence the Enolase,
an enzyme involved in glycolysis. Cellular extracts prepared from
HeLa cells transfected with the appropriate siRNA for 72 h
efficiently and specifically reduced the expression of PKC i, COPI,
Rab 2 and Enolase (Figure 6A), whereas, siRNA control did not
(Figure 6A). Figure 6B shows the intracellular replication of B.
abortus at 48 h p.i. within infected-HeLa cells transfected with
different siRNAs. Brucella replication was reduced 2.2, 2.3 and 5
fold in cells transfected with PKC i siRNA, Rab 2 A siRNA and
COP B siRNA, respectively as compared to cells transfected with
the siRNA-A control. This result indicates that each member of
the complex GAPDH/COPI/Rab2/PKCi/l is required for
Brucella replication. Surprisingly, we noticed that the intracellular
replication of Brucella was reduced 4 fold under the inhibition of
Enolase expression. This result suggests that host glycolysis is
necessary for Brucella survival within host cells. Taken together,
these results demonstrate the role played by the early secretory
pathway, in particular the GAPDH/COPI/Rab2/PKCi/l retro-
grade vesicles, to ensure replication within host cells at late stages
of infection.
Discussion
Many intracellular bacteria, with the aim of generating a
suitable niche of replication, have been shown to alter the
phagosomal membrane composition to avoid fusogenic interac-
tions with lysosomes [24]. For example, Salmonella typhimurium
secretes multiple effector molecules onto the vacuolar membrane
(via its type III secretion systems), which interact with host proteins
to modulate vesicle transport and vacuolar membrane dynamics
Figure 4. Recruitment of the active form of Rab 2 (Rab 2 Q65L) on BCV. (A) Quantification of the percentage of BCV positive in myc Rab 2
Q65L transfected HeLa cells and infected with B. abortus GFP at different time p.i. (B) Confocal micrographs of a myc Rab 2 Q65L transfected Hela cell
infected with B. abortus GFP at 10 h p.i. The myc tag was immunostained with anti-myc antibody. The arrow indicates myc Rab 2 Q65L accumulation
around BCVs. (Scale bar: 10 mm).
doi:10.1371/journal.ppat.1000487.g004
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PLoS Pathogens | www.plospathogens.org 6 June 2009 | Volume 5 | Issue 6 | e1000487Figure 5. The inhibition of GAPDH expression and the dominant negative of Rab 2 affects B. abortus replication at 48 h p.i. (A) Fold
increase of intracellular CFUs at 48 h p.i. of Hela cells infected with B. abortus Ds Red. Infected cells were transfected or not with GFP, myc Rab 2, myc
Rab 2 I119, GFP Rab 1 or GFP Rab 1 S25N at 2 h p.i. Data are means6SD of three independent experiments. (B) Confocal micrographs of Hela cells
infected with B. abortus Ds red and transfected with myc Rab 2 or its dominant negative myc Rab 2 I119. The myc tag was immunostained with anti-
myc antibody (Scale bars: 10 mm). (C, D, E) Quantification of the percentage of BCV positive for LAMP-1 (C), Calnexin (D) or Cathepsin D (E) in myc Rab
2 I119 transfected HeLa cells (open circle) or not (open square) and infected with B. abortus wild-type. (F) Western blotting of cellular extracts from
cells transfected with GAPDH siRNA or siRNA control. Immunoblotting with anti-GAPDH and anti-actin antibodies. (G) Fold increase of intracellular
CFUs at 48 h p.i. of transfected Hela cells with GAPDH siRNA or siRNA control and infected with B. abortus. Data are means6SD of three independent
experiments. (H) Confocal micrographs of Hela cells infected with B. abortus Ds red and transfected with GAPDH siRNA or siRNA control. GAPDH was
immunostained with anti-GAPDH antibody (Scale bars: 10 mm).
doi:10.1371/journal.ppat.1000487.g005
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PLoS Pathogens | www.plospathogens.org 7 June 2009 | Volume 5 | Issue 6 | e1000487Figure 6. The inhibition of PKC i/l, COPI, Rab 2 and Enolase expression affects B. abortus replication at 48 h p.i. (A) Western blotting of
cellular extracts from cells transfected with PKC i siRNA, COP B siRNA, Rab 2 A siRNA, Enolase siRNA or control siRNA-A. Immunoblotting with anti-PKC
i, -COP B, -Rab 2 A, -Enolase and anti-actin antibodies. (B) Fold increase of intracellular CFUs at 48 h p.i. of transfected Hela cells with PKC i siRNA, COP
B siRNA, Rab 2 A siRNA, Enolase siRNA or control siRNA-A and infected with B. abortus. Data are means6SD of three independent experiments.
doi:10.1371/journal.ppat.1000487.g006
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with late endosomes whilst avoiding fusion with lysosomes. In
contrast, Legionella and Brucella replicate in ER-derived compart-
ments [1,26]. In the case of Legionella, several recent studies have
highlighted the role of type IV secreted proteins in recruiting
eukaryotic proteins to the vacuolar membrane and by mechanisms
that are still unclear sustain intracellular replication [27]. Much
less in known for Brucella, particularly regarding the membrane
composition of BCVs. Previous work has demonstrated that the
small GTPase Sar1 is implicated in Brucella intracellular survival
[10]. However, apart from ER-resident proteins no other
eukaryotic molecules have been associated with the BCV
membrane.
Phagosomal proteomic studies using latex bead-containing
phagosomes have significantly helped to decipher phagosome
biology [28]. Using a modified procedure for phagosome
purification, we analysed in detail the protein composition of the
BCV membrane in order to identify eukaryotic proteins recruited
to BCVs during intracellular replication. We developed a
fractionation method to isolate intact BCVs from infected BHK-
21 cells. This method allowed us to establish for the first time the
BCV membrane protein map of the replicative niche of Brucella.A s
expected, a proportion of proteins on the BCV membrane were
ER and ribosomal proteins.
Interestingly, one of the proteins identified was GAPDH, a non-
ER eukaryotic protein which is normally located on VTCs
between ER and the Golgi apparatus. This protein has been
extensively studied by Tisdale et al [29–35]. GAPDH forms an
active complex with the small GTPase Rab 2 and the protein
kinase C (PKCi/l), which is necessary for secretory vesicular
transport. First studies showed that an inactive form of Rab 2 had
a negative effect on anterograde transport of vesicles from the ER
to the Golgi [21]. Recently, the group of Tisdale has shown that
Rab 2 modulates protein retrograde transport from the Golgi to
the ER by recruiting GAPDH to VTCs which allows the release of
retrograde-directed vesicles [31,35]. This retrograde transport
requires a functional GAPDH/COPI/Rab2/PKCi/l complex.
Presence of GAPDH and Rab 2 on the BCV membrane suggests
that Brucella is somehow interacting with VTCs or intercepting
vesicle trafficking of the retrograde transport. Consistent with this
hypothesis we found that inhibition of GAPDH resulted in
reduced intracellular replication of Brucella. However, we cannot
exclude that its role in the host cell glycolysis also contributes to
the intracellular survival of Brucella. Indeed, silencing of enolase,
another enzyme involved in glycolysis, also resulted in inhibition of
Brucella replication. Further work is necessary to determine if
Brucella is directly using the host glycolysis to its advantage, for
example as a source of energy.
Nevertheless, the implication of retrograde transport in Brucella
virulence is clearly demonstrated by the inhibition of the bacterial
replication upon silencing of each member of the complex
GAPDH/COPI/Rab2/PKCi/l.
In addition, we found that Rab 2 is recruited on the BCV
membrane before fusion with the ER suggesting that the
retrograde transport might have an important role in the
establishment of the bacterial replicative niche. Previous work
has demonstrated that BCV-ER fusion events occur specifically at
ER exit sites and are mediated by the small GTPase Sar1. This
work also demonstrated that the anterograde pathway mediated
by COPI/ARFI-coated vesicles are not involved in the BCV-ER
fusion and that COPII complex formed on ER membranes was
found in close apposition to BCV [10]. Our results also implicate
the small GTPase Rab 2, in the early events of BCV biogenesis
since inactivation of Rab 2 using the dominant negative prior to
infection prevented fusion of BCVs with the ER. When
inactivation is performed after infection, Brucella is able to start
to replicate at 24 h (data not shown) whereas at 48 h p.i. there is a
strong replication effect. Overall, these results suggest that Rab 2 is
also necessary for Brucella survival after it has established its ER-
derived replication niche.
Consistent with this hypothesis, we found that Brucella
replication was also affected with prolonged brefeldin A treatment,
which causes the Golgi apparatus to redistribute to the ER (data
not shown). Regeneration of the Golgi apparatus after brefeldin A
treatment allowed Brucella to recover and replicate (data not
shown). Therefore, it is possible that trafficking of secretory vesicles
from the Golgi apparatus to the ER is beneficial for Brucella
replication. Perhaps, extensive bacterial replication requires an
additional membrane input that may come from vesicles from the
secretory pathway.
Brucella seems to manipulate host cells differently than Legionella
pneumophila, another bacterial pathogen which replicates in the ER.
Indeed, Legionella was shown to manipulate host cells by secreting
specific type IV secretion system bacterial effectors, for example
DrrA (or LidA) [36,37]. DrrA is able to mimic the guanosine
exchange factor (GEF) of the small GTPase Rab 1 to catalyse the
exchange of GDP to GTP which lead to the activation and the
recruitment of Rab 1 on the Legionella-containing vacuole [36,37].
Interestingly, another secreted effector LepB acts like a GTPase-
activating protein (GAP) which inactivates Rab 1 [38]. Inhibition
of Rab1 impairs Legionella replication [22]. In this study, we
demonstrate that Rab 1 is not involved in intracellular replication
of Brucella.
Rab 1 is implicated in the anterograde pathway whereas Rab 2
is also essential for the retrograde pathway. After 24 h of
replication within its ER-derived vacuole, Legionella lyses its
vacuole to reach the cytosol and to infect the neighbouring host
cells [39]. This suggests that Legionella does not need an influx of
membrane since the bacteria lyse the host cell relatively quickly
compared to Brucella, which continues to replicate within vacuoles
for a long period of time (at least another 48 h) [1]. Therefore it is
possible that Brucella might require an extensive influx of
membrane for its own survival. Targeting of the retrograde
pathway could ensure continued fusion with incoming vesicles and
an influx of membrane.
At this stage, it is unclear how Brucella is controlling biogenesis of
ER-derived BCVs. It is possible that some secreted effector
proteins not yet identified are directly recruiting GAPDH and Rab
2 to the BCV membrane. The type IV secretion system VirB,
essential for sustained interaction and fusion with ER membranes
[1], could secrete these effectors to recruit Rab 2 onto the BCV
membrane. We are currently undertaking further studies to
identify the bacterial effector(s) which target(s) Rab 2 and
GAPDH.
Materials and Methods
Bacterial strains
The bacterial strains used in this study were the smooth virulent
B. abortus strain 2308 GFP [1] or 2308 Ds Red kindly provided by
Jean-Jacques Letesson (URBM, Immunology Laboratory,
FUNDP, Namur, Belgium). Bacteria were inoculated in tryptic
soy broth (TSB. Sigma-Aldrich) with kanamycin and grown at
37uC overnight (16 h) as previously described for infections [1].
Plasmids
GFP vector used was pEGFP-C1 (Clontech). Plasmids pGEM
Rab 2, pGEM Rab 2 I119 and pGEM Rab 2 Q65L were kindly
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University School of Medicine, New Haven, USA). The rab2
sequence from the vectors pGEM Rab 2, pGEM Rab 2 I119
and pGEM Rab 2 Q65L was amplified by PCR with two
specific primers: O-403 (59GGGGACAAGTTTGTA-
CAAAAAAGCAGGCTTCGCGTACGCCTATCTCTTCAAG-
TACAT39) and O-404 (59GGGGACCACTTTGTACAA-
GAAAGCTGGGTCCTAACAGCAGCCGCCCC-
CAGCCTGCTG39). The myc tag (pCMV-myc) was added by
Gateway procedure according to the manufacturer’s instructions
(Invitrogen) to obtain myc Rab 2, myc Rab 2 I119 and myc Rab 2
Q65L. Plasmids GFP Rab 1 and GFP Rab 1 S25N were also
kindly given by Craig Roy. The silencing of endogenous GAPDH
was performed by small interfering RNA with the commercial
siRNA GAPDH (Applied Biosystems Ambion). A negative control
siRNA was also used (Applied Biosystems Ambion) as a
transfection control. Silencing of endogenous PKC i, COP B,
Rab 2 A and a-Enolase were performed by small interfering RNA
with the corresponding commercial siRNA (Santa Cruz Biotech-
nology). A negative control siRNA-A was also used (Santa Cruz
Biotechnology) as a transfection control.
Antibodies
The primary antibodies used were: a mouse monoclonal anti-
actin given by Lena Alexopoulou (CIML, Marseille, France); a
rabbit polyclonal anti-calnexin (Stressgen); a rabbit polyclonal
anti-cathepsin D [40]; a goat polyclonal T-14 COP B (Santa Cruz
Biotechnology); a mouse monoclonal anti-GAPDH (Sigma
Aldrich); a rabbit polyclonal anti-giantin (Covance); a mouse
monoclonal anti-GM130 (Transduction Laboratories); a rabbit
polyclonal anti-LAMP-1 (Abcam); a mouse monoclonal 4A1 anti-
LAMP-1 kindly given by Jean Gruenberg (University of Geneva,
Switzerland); a mouse monoclonal 9E10 anti-c-myc tag (Santa
Cruz Biotechnology); a mouse monoclonal anti-Omp 25 (A59/
05F01/C09) kindly given by Michel Zygmund (INRA, Tours,
France); a mouse monoclonal H-12 PKC i (Santa Cruz
Biotechnology); a rabbit polyclonal anti-Rab 1 (Santa Cruz
Biotechnology); a polyclonal rabbit anti-Rab 2 and a mouse
monoclonal anti-Rab 5 kindly given by Marino Zerial (Max
Planck Institute of Molecular Cell Biology and Genetics, Dresden,
Germany); a rabbit polyclonal anti-Rab 7 [40] and a rabbit
polyclonal anti-VDAC 1 (Abcam). The secondary antibodies used
were: goat anti-mouse HRP (Sigma Aldrich); goat anti-rabbit HRP
(Sigma Aldrich) for western blotting; and donkey anti-rabbit Texas
red (Jackson ImmunoResearch); donkey anti-mouse Texas red
(Jackson ImmunoResearch); donkey anti-mouse Cy3 (Jackson
ImmunoResearch); donkey anti-mouse FITC (Jackson ImmunoR-
esearch); donkey anti-mouse Cy5 (Jackson ImmunoResearch);
phalloidin-tetramethylrhodamine isothiocyanate (TRITC. Sigma
Aldrich) for immunofluorescence and a IgG anti-rabbit coupled to
phycoerytrin (PE. Serotec) for flow cytometry.
Cell culture, infection and transfection
Baby hamster kidney (BHK-21) cells were cultured at 37uC with
5% CO2 atmosphere in GMEM (Glasgow’s modified Eagle’s
medium. Gibco) supplemented with 10% Tryptose Phosphate
Broth (Sigma Aldrich), 5% FCS (Perbio) and 1% L-glutamine
(Gibco) and seeded 24 h before infection on 55 cm
2 culture dishes
(1.6610
6 cells per dish) for fractionation or at a surface ratio of 1/
10 in 24-well plates containing 12-mm glass coverslips for
immunofluorescence and CFUs. HeLa cells and Raw 264.7
macrophages were cultured at 37uC in a 5% CO2 atmosphere in
DMEM supplemented with 10% FCS, 1% non-essential amino
acids and 1% L-glutamine and seeded 24 h before infection at a
surface ratio of 1/10 in 24-well plates containing 12-mm glass
coverslips. Bone marrow-derived macrophages (BMDM) were
isolated from femurs of 6 to 10-week-old C57Bl/6 female mice
and differentiated into macrophages as previously described [41].
Infections were performed at a multiplicity of infection of 200:1
by centrifuging bacteria onto BHK-21, HeLa cells, BMDM or
Raw 264.7 macrophages at 400 g for 10 min at 4uC, and then by
incubating the cells for 1 h (for BHK-21 and HeLa cells) or
15 min (for BMDM and Raw 264.7 macrophages) at 37uC under
a5 %C O 2 atmosphere. Cells were extensively washed with their
respective medium to remove extracellular bacteria and were
incubated for an additional hour in their respective medium
supplemented with 50 mg/ml gentamycin to kill extracellular
bacteria. Thereafter, the antibiotic concentration was decreased to
10 mg/ml.
To monitor Brucella intracellular survival, infected cells were
washed three times with PBS and lysed with 0.1% (vol/vol) Triton
X-100 in PBS. Serial dilutions in PBS of lysates were plated onto
TSB agar plates to enumerate CFUs.
The expression of GFP, myc Rab 2, myc Rab 2 I119, myc Rab
2 Q65L, GFP Rab 1, GFP Rab 1 S25N were performed by
transfecting HeLa cells using the FuGENE transfection reagent
(Roche), according to the manufacturer’s instructions. Depending
of experiment, transfections were performed either 24 h before or
2 h after Brucella infection and were left to proceed until the time of
analysis.
The transfection of small interfering RNA si GAPDH and
siRNA control were performed on HeLa cells using the
siPORT
TM Amine transfection agent (Applied Biosystems Am-
bion) according to the manufacturer’s instructions. The transfec-
tion of PKC i, COP B, Rab 2 A, a-Enolase siRNAs and control
siRNA-A were performed on HeLa cells using the siRNA
Transfection Reagent (Santa Cruz Biotechnology) according to
the manufacturer’s instructions. 24 h later, transfected HeLa cells
with the specific siRNA or siRNA-A control were infected with B.
abortus as described before. To maintain the silencing of these
specific proteins, HeLa cells were again transfected 2 h p.i.
Cellular extracts were prepared after lysis of HeLa cells
transfected 72 h with either siGAPDH or siRNA control with
0.1% (vol/vol) Triton X-100 in PBS.
Fractionation method
At 48 h p.i., 6 infected BHK-21 55 cm
2 dishes were washed
once with GMEM. 1 ml of GMEM was added and infected cells
were recovered by scraping with a rubber policeman. Then,
several steps of washes were done with PBS, PBS/1 mM EDTA,
pH 7.4, homogenization buffer (3 mM imidazole/250 mM su-
crose/0.5 mM EDTA/0.5 mM EGTA, pH 7.4). A centrifugation
at 80 g for 5 min at 4uC was performed between each wash.
Pellets were resuspended very gently in the homogenization buffer
and cells were mechanically broken through 5 passages into a 22G
needle. PNS were recovered after a centrifugation at 80 g for
10 min at 4uC. Then, a first step of purification was performed by
loading the PNS on the top of a 50%–12% sucrose gradient. After
centrifugation at 800 g for 45 min at 4uC, a cloudy layer
containing BCVs appeared at the 50%–12% interface. This
cloudy layer (called interface fraction) was carefully recovered and
loaded at the bottom of a SW 60 centrifugation tube. Three layers
of sucrose were sequentially added on top of the interface fraction:
30%, 20% and 5% sucrose respectively. The enriched BCV
fraction was obtained after an ultracentrifugation at 35000 rpm
for 1 h at 4uC and was localized in the pellet. The pellet was then
resuspended in the homogenization buffer. Depending of
experiments, a supplementary step was added between the two
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the enriched BCV fraction. This step consisted of incubating the
interface fraction with dynabeads (M-500 subcellular, Invitrogen)
coated with a rabbit anti-VDAC 1 antibody (according to the
manufacturer’s instructions) overnight recovering the supernatant
from dynabeads retained with a magnet (according to the
manufacturer’s instructions).
Flow cytometry
BCV staining within PNS was adapted from what was
previously described [40]. PNS was incubated with a rabbit anti-
calnexin antibody and then incubated with a rabbit-PE antibody
30 min on ice. The preparation was fixed for 20 min in 3% final
PFA and then diluted to 1% final PFA before analysis on a
FACScalibur cytometer (Becton Dickinson). Data were analysed
using FlowJo software (Tree Star).
Preparation of 2D gel samples
250 mg of the enriched fraction of BCVs was treated for 30 min
at room temperature with 0.1% Triton X-100. The BCV
membranes were separated from bacteria by centrifugation at
10000 rpm for 5 min at 4uC. The corresponding supernatants
enriched in BCV membrane proteins were precipitated with
trichloroacetic acid (Sigma Aldrich) 10% final for 5 min on ice and
then with trichloroacetic acid 5% final for 5 min on ice.
Trichloroacetic acid was then removed by three washes with
90% acetone. Each step was followed by a centrifugation at
10000 rpm for 3 min at 4uC. The pellet was finally resuspended in
400 ml of destreack rehydration buffer containing 2% carrier
ampholytes pH 3–10 (IPG Amersham Biosciences).
2-D gel electrophoresis
BCV membrane proteins were separated by isoelectric focusing
(IEF). The IEF was performed using 18 cm gels with an
immobilized linear pH gradient of 3–10 (Immobiline DryStrips,
Amersham Biosciences) in IPGphor strip holders (Amersham
Biosciences) on a MultiphorII machine (Amersham Biosciences).
The IEF protocol was as follows: 300 V for 1 min; 500 V gradient
for 30 min; 3500 V gradient for 1.5 h; 3500 V for 6 h.
Temperature was set at 20uC. Prior to SDS PAGE, IPG strips
were equilibrated during 20 min in an equilibration buffer (6 M
urea, Tris, pH 8.8, 50 mM, 2% SDS, 65 mM DTT, 38.5%
glycerol). The second dimension was performed using a Protean II
xl Multicell separation unit (Biorad) and home-made 10% SDS
PAGE gels. Temperature was set at 20uC. Gels, made of Tris-
HCl, 0.1% SDS and 10% acrylamide were run at 20uC using the
following running buffer (25 mM Tris, 192 mM glycine and 0.1%
SDS) for the cathode part and 26running buffer for the anode.
Electrophoresis was conducted at 10 mA per gel overnight and
stopped when the bromophenol blue front dye reached the bottom
of the gel. Proteins were stained by a PlusOne Silver Staining Kit,
Protein (GE Healthcare) according to the manufacturer’s
instructions (without glutaraldehyde to allow the mass spectrom-
etry analysis).
In-gel digestion and MALDI-TOF MS
Protein spots immediately excised from silver-stained gels were
destained and subjected to in-gel digestion with trypsin (Sequenc-
ing grade modified porcine trypsine; Promega, Madison, WI,
USA) according to a modified protocol from Shevchenko et al.
[42]. Tryptic peptides were then extracted from the gel by
successive treatment with 5% formic acid and 60% acetonitrile/
5% formic acid. Extracts were pooled and dried in a Speedvac
evaporator. Peptides resuspended in an a cyano-4-hydroxycin-
namic acid matrix solution (prepared by diluting 6 times a
saturated solution in 50% acetonitrile/0.3% trifluoroacetic acid),
were then spotted on the metal target. Mass analyses were
performed on a MALDI-TOF Bruker Ultraflex spectrometer
(Bruker Daltonics, Wissembourg, France). Mass spectra were
internally calibrated using autolytic peptides from trypsin.
Database searching and data interpretation
The peptide mass lists were used to identify the protein using
Mascot software available on site. Criteria used for protein
identification are given by Mascot as a Probability Based Mowse
Score. Ions score is 210*Log(P), where P is the probability that the
observed match is a random event. Protein scores greater than X
(X is a number between 60 and 74, from one search to the other)
are significant (p,0.05).
Western blotting
The protein concentration was determined with the BCA
TM
Protein Assay Kit (Pierce). Volumes corresponding to 60 mgo f
proteins from each main step of the fractionation were
resuspended in 16laemmeli-buffer and loaded on a 12% SDS
polyacrylamide gel. Then proteins were transferred onto a PVDF
membrane using a semi-dry transfer. The PVDF membrane was
then blocked for 1 h with 4% milk/PBS/0.1% Tween 20 and
incubated with different antibodies. The PVDF membrane was
washed 3 times with PBS/0.1% Tween 20 before incubation with
the secondary antibody and the detection. The detection was
carried out using the ECL
TM western blotting detection kit
(Amersham).
Fluorescence microscopy
To analyse the PNS and the sucrose step gradient enriched in
BCVs, 10 ml of sample were put in 24-well plates containing 12-
mm glass coverslips pre-treated with poly-L-lysine and incubated
for 15 min at 37uC to allow the adherence onto glass coverslips.
Then BCVs or infected cells were fixed with 3% paraformal-
dehyde, pH 7.4 at room temperature for 15 min, and then
processed for immunofluorescence staining as described previ-
ously [5]. Specimens were observed on a Zeiss LSM 510 laser
scanning confocal microscope for image acquisition. Images of
102461024 pixels were acquired and assembled using Adobe
Photoshop CS2.
Processing for electronic microscopy
B. abortus-infected BHK cells were fixed for 1 h at room
temperature with 2.5% glutaraldehyde (Sigma, St Louis, MO,
USA) in 0.1 M cacodylate buffer, pH 7.2, containing 0.1 M
sucrose, 5 mM CaCl2 and 5 mM MgCl2. After two successive
15 min washes with the same buffer, cells were postfixed for 1 h at
room temperature with 1% osmium tetroxide (Electron Micros-
copy Sciences, Hatfield, PA, USA) in the same buffer devoid of
sucrose. The cells were scraped off the culture dishes with a rubber
policeman and concentrated in 2% agarose in the same buffer.
After 1 h incubation at room temperature with 1% uranyl acetate
in veronal buffer, the samples were dehydrated in a graded series
of acetone and embedded in Epon resin. Thin sections were
stained with uranyl acetate and lead citrate. The PNS and
enriched BCVs obtained from the BHK-infected cells were first
prefixed for 20 min at room temperature with 5% glutaraldehyde
in cacodylate buffer diluted at a 1:1 volume ratio with the PNS or
BCV fractions. These fractions were then processed as described
above for BHK-infected cell.
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Figure S1 Flow cytometry analysis of BCVs in the PNS: (A)
BCV-GFP within the PNS is indicated by the GFP+ gate. (B)
BCV-GFP subpopulation positive for the ER marker calnexin is
indicated by the GFP+ ER+ gate. FL-1 indicates GFP fluorescence
intensity and FL-2 indicates calnexin-PE fluorescence intensity.
Found at: doi:10.1371/journal.ppat.1000487.s001 (0.93 MB TIF)
Figure S2 The dominant negative of Rab 2 but not that of Rab
1 affects B. abortus replication. (A) Confocal micrographs of Hela
cells infected with B. abortus Ds red and transfected or not with
GFP, GFP Rab 1 or its dominant negative GFP Rab 1 S25N
(Scale bars: 10 mm). (B) Confocal micrographs of Hela cells
infected with B. abortus GFP and transfected with the dominant
negative of Rab 2 (Rab 2 I 119) at 48 h p.i. Late endosomal
compartments and the myc tag were immunostained with anti-
LAMP-1 and anti-myc antibodies respectively (Scale bars: 10 mm).
Found at: doi:10.1371/journal.ppat.1000487.s002 (1.97 MB
DOC)
Figure S3 Inhibition of expression of GAPDH prevents Rab2 to
be recruited on BCVs. Purified BCVs from either control siRNA-
or GAPDH siRNA-treated BHK cells were analysed by confocal
microscopy for the presence of Rab2 (in red) immunostained with
rabbit polyclonal anti-Rab2 antibody and LAMP-1 (in white)
immunostained with mouse 4A1 monoclonal antibody (Scale bars:
5 mm).
Found at: doi:10.1371/journal.ppat.1000487.s003 (0.25 MB TIF)
Table S1 Proteic composition of isolated BCV: both eukaryotic
and bacterial proteins are present on the BCV membrane. Each
spot of the 2D gel electrophoresis of BCV membranes was
analysed by mass spectrometry and identified by matching with
the Mascot database software available on site.
Found at: doi:10.1371/journal.ppat.1000487.s004 (0.03 MB XLS)
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